BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Trends Analyst Outlook Journalist POV

63 hedge funds and large institutions have $25.4M invested in BioCryst Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$124K
Puts
$167K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$8.62M
2
$2.5M
3
$2.23M
4
$1.8M
5
$1.79M
6
$1.57M
7
$767K
8
$504K
9
$468K
10
$355K
11
$338K
12
$321K
13
$281K
14
$280K
15
$278K
16
$268K
17
$262K
18
$227K
19
$216K
20
$192K
21
$183K
22
$171K
23
$160K
24
$131K
25
$115K
1
2 3